ENDPOINTS NEWS13h
23andMe weighs a sale as cash dwin­dles
Em­bat­tled ge­net­ics test­ing gi­ant 23andMe is think­ing of sell­ing it­self as it runs out of cash. The com­pa­ny needs ...
pharmaphorum14h
To protect sciences and pharma in an RFK Jr era, put consumer education first
It is incumbent not only on people to have the willingness to learn, but also on pharmaceutical and scientific industries to ...